Publications by authors named "Elizabeth Taras"

Claim this Profile
I
Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
Antonella Borgatti, Ann Fieberg, Amber L Winter, Kathleen Stuebner, Elizabeth Taras

Vet Comp Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin.
Felix Oh, Deborah Todhunter, Elizabeth Taras, Daniel A Vallera, Antonella Borgatti

Clin Pharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors.
Kristy Pilbeam, Hongbo Wang, Elizabeth Taras, Rachel J Bergerson, Brianna Ettestad

Oncotarget· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell Malignancies.
Joerg U Schmohl, Deborah Todhunter, Elizabeth Taras, Veronika Bachanova, Daniel A Vallera

Toxins (Basel)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker.
Joerg U Schmohl, Martin Felices, Deborah Todhunter, Elizabeth Taras, Jeffrey S Miller

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker.
Joerg U Schmohl, Martin Felices, Elizabeth Taras, Jeff S Miller, Daniel A Vallera

Mol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.
Amy P N Skubitz, Elizabeth P Taras, Kristin L M Boylan, Nate N Waldron, Seunguk Oh

Gynecol Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy.
Daniel A Vallera, Hua Chen, Andrew R Sicheneder, Angela Panoskaltsis-Mortari, Elizabeth P Taras

Leuk Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy of CD45-expressing Daudi tumors in nude mice with yttrium-90-labeled, PEGylated anti-CD45 antibody.
Daniel A Vallera, Andy R Sicheneder, Elizabeth P Taras, Martin W Brechbiel, Jesse A Vallera

Cancer Biother Radiopharm· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo imaging of graft-versus-host-disease in mice.
Angela Panoskaltsis-Mortari, Andrew Price, John R Hermanson, Elizabeth Taras, Chris Lees

Blood· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-BMT lung injury occurs independently of the expression of CCL2 or its receptor, CCR2, on host cells.
Angela Panoskaltsis-Mortari, John R Hermanson, Elizabeth Taras, O Douglas Wangensteen, Israel F Charo

Am J Physiol Lung Cell Mol Physiol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice.
Angela Panoskaltsis-Mortari, John R Hermanson, Elizabeth Taras, O Douglas Wangensteen, Jonathan S Serody

Blood· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis